Le Car-T nella terapia della leucemia linfoblastica acuta: quale bilancio?
In which patients and at what stage of the disease can CAR-T cells be used today? They are currently used in the treatment of relapsed or refractory acute lymphoblastic leukemia, meaning in cases of failure to respond to induction therapy or relapse after remission. The pioneering studies were conducted in pediatric patients, while subsequent studies have been conducted in young adults/adolescents and adults. Dr. Alessandro Isidori, Division of Hematology and Transplant Center, San Salvatore Hospital in Pesaro, spoke to PharmaStar about this topic during the first edition of the Clinical & Biological School of CAR-T, an event organized by SOHO Italy.
▶︎
La Leucemia Linfoblastica Acuta
▶︎
Le CAR-T sono efficaci e sicure? Il bilancio dopo oltre due anni di pratica clinica
▶︎
Leucemia linfoblastica acuta, quali sono le novità nel trattamento nel paziente adulto?
▶︎
Mieloma multiplo, la guarigione è possibile?
▶︎
Multiple Myeloma: The Real Needs of Patients and Caregivers
▶︎
CLL Patient Stories: My Chronic Lymphocytic Leukemia First Symptoms & Diagnosis | Tamsin W. (1 of 3)
▶︎
Myeloma 101: Understanding Multiple Myeloma, Risk Factors, Diagnosis & Treatments Explained
▶︎
Cellule CarT, la prima terapia genica contro il cancro
▶︎
Leucemia linfoblastica acuta Ph+, malattia oggi curabile grazie all’intuizione di Michele Baccarani
▶︎
She’s 12. She Sings Aretha Franklin… Until Simon TELLS Her to Do It Acapella! 😳
▶︎
Le novità sul mieloma multiplo
▶︎
La recidiva nei tumori ematologici
▶︎
TGR Rai Puglia: proseguono gli studi sulla leucemia linfoblastica acuta dell'IRCCS Casa Sollievo
▶︎
Before you Start or Refuse Cancer Therapy- WATCH THIS!
▶︎
Non-hodgkin lymphoma - causes, symptoms, diagnosis, treatment, pathology
▶︎
Early Signs of Autoimmune Diseases
▶︎
Leucemia linfoblastica acuta, a che punto siamo con le terapie con cellule CAR-T?
▶︎
Diagnosis and monitoring of Multiple Myeloma
▶︎
XV FORUM NAZIONALE AIPaSiM, VERONA 23 maggio 2026, ore 14.30
▶︎